Evaluations included the Peritoneal Cancer Index (PCI), tumor weight, histopathology (Peritoneal Regression Grading Score [PRGS]), imaging, and markers of proliferation (Ki-67) and apoptosis (TUNEL). The gene discussed is MKI67; the disease is peritoneum cancer.